BC Week In Review | Nov 14, 2011
Clinical News

Architect HBsAg Qualitative II assay regulatory update

Abbott received CE Mark approval for its Architect HBsAg Qualitative II assay to aid in the diagnosis of HBV infection and for screening donated blood and plasma. The chemiluminescent microparticle immunoassay for hepatitis B surface...
Items per page:
1 - 1 of 1